Owens & Minor Announces Major Innovations to Products & Healthcare Services Network | OMI Stock News

Author's Avatar
Apr 09, 2025
Article's Main Image
  • Owens & Minor (OMI, Financial) is advancing its medical distribution capabilities with new technology and automation.
  • Two state-of-the-art distribution centers are being introduced in West Virginia and South Dakota.
  • The initiative is part of a two-year plan aimed at enhancing customer experience and operational efficiency.

Owens & Minor, Inc. (OMI) has unveiled significant developments in their Products & Healthcare Services (P&HS) segment, focusing on improvements in medical distribution. The enhancements utilize cutting-edge technology, automation, and analytics to bolster supply chain visibility and efficiency.

The company's strategy involves the launch of two new state-of-the-art distribution centers. The West Virginia facility, already operational, boasts advanced automation and robotics technology designed to streamline inventory management and expedite order fulfillment. Meanwhile, a center in South Dakota, set to open in the spring of 2025, will incorporate augmented reality (AR) technology to enhance the order picking process.

This initiative is a part of Owens & Minor's two-year plan aimed at refining customer experience and operational efficiency in the P&HS segment, which serves thousands of healthcare clients. The implementation of these technologies is expected to reduce labor costs, decrease error rates, and improve inventory accuracy, ultimately enhancing the overall service delivery.

These advancements signal a strategic move by Owens & Minor to address recent supply chain challenges and align with industry-wide recognition of the need for resilient distribution networks. By focusing on these technology-driven improvements, OMI aims to solidify its competitive standing against major players in the medical distribution sector.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.